Author
Listed:
- Either Karim El-Adham
(Radioisotope Department, Nuclear Research Center, Atomic Energy Authority, Dokki 12311, Giza, Egypt)
- Kahled Mohamed Salama
(Faculty of Medicine, Cairo University, Egypt)
Abstract
Anti-Mullerian hormone (AMH) is a glycoprotein, a member of the transforming growth factor-B super family. This hormone is a sensitive marker of ovarian reserve. The present study aims to measure the Anti-Mullerian hormone in thalassemic females receiving the regular blood transfusion as well as patients of chronic idiopathic thrombocgtopenic purpura and age and sex matched controls. Serum Anti-Mullerian hormone was measured by ELISA and Ferritin were measured by RIA. Clinical evaluation was done for all patients including anthropometric measurements, pubertal staging and history taking. Results of the study were analyzed by appropriate statistical methods. Obtained results revealed that the values of Body Mass Index as well as Anti-Mullerian were significantly higher in controls than thalassemics and chronic idiopathic thrombocytopenic purpura and there was a negative correlation between serum Ferritin and Anti-Mullerian hormone. Moreover, Anti-Mullerian hormone was significantly higher in patients receiving Desferal than in those receiving Deferriprone. Reduced Anti-Mullerian hormone in thalassemics as well as chronic ITP patients are considered an important indicator declines in ovarian function which entail modification in the therapeutic plans for thalassemic and chronic ITP patients.
Suggested Citation
Either Karim El-Adham & Kahled Mohamed Salama, 2016.
"Anti Mullerian Hormone in Transfusion Dependent B- Thalassemia and Chronic Idiopathic Thrombocytopenic Purpura,"
International Journal of Healthcare and Medical Sciences, Academic Research Publishing Group, vol. 2(12), pages 66-71, 12-2016.
Handle:
RePEc:arp:ijohms:2016:p:66-71
DOI: arpgweb.com/?ic=journal&journal=13&info=aims
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:arp:ijohms:2016:p:66-71. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Managing Editor (email available below). General contact details of provider: http://arpgweb.com/index.php?ic=journal&journal=13&info=aims .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.